CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 2,371	$ (82,037)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation expense	5,987	6,148
Depreciation and amortization expense	523	357
Gain on sale of non-financial asset (Note 17)	(105,000)	0
Non-cash lease expense	1,179	1,173
Accretion of debt discount	655	681
Change in fair value of warrant liability	(4,596)	(743)
Other	(504)	(46)
Changes in operating assets and liabilities:
Inventory, Net	(2,445)	0
Prepaid expenses, other current and non-current assets and research and development incentive receivable	1,197	459
Accounts payable	(364)	426
Accrued expenses and other long-term liabilities	3,832	5,651
Lease liabilities	(741)	(834)
Net cash used in operating activities	(97,906)	(68,765)
Cash flows from investing activities:
Acquisition of intangible asset	(7,000)	0
Proceeds from sale of non-financial asset	105,000	0
Purchase of marketable securities	(34,354)	(11,025)
Sales and maturities of marketable securities	12,250	1,000
Acquisition of property and equipment	(285)	(25)
Net cash provided by (used in) investing activities	75,611	(10,050)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock	159	8,615
Fees paid to amendment loan agreement and issuance costs related to the sale of warrants	0	(631)
Repayments of borrowings and accrued end-of-term fees under loan and security agreement	0	(2,064)
Proceeds from borrowings under loan and security agreement	20,000	22,500
Proceeds from sale of common stock, warrants and pre-funded warrants, net of issuance costs	0	59,999
Net cash provided by financing activities	20,159	88,419
Effect of exchange rate changes on cash, cash equivalents and restricted cash	88	(28)
Net increase in cash, cash equivalents and restricted cash	(2,048)	9,576
Cash, cash equivalents and restricted cash at beginning of period	100,248	123,028
Cash, cash equivalents and restricted cash at end of period	98,200	132,604
Supplemental Cash Flow Information [Abstract]
Acquisition of intangible assets included in accrued expenses	$ 3,500	$ 0